Page last updated: 2024-08-24

acridine orange and Atherosclerotic Parkinsonism

acridine orange has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kish, SJ; Tatton, NA	1

Other Studies

1 other study(ies) available for acridine orange and Atherosclerotic Parkinsonism

Article	Year
In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience, 1997, Volume: 77, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acridine Orange; Animals; Apoptosis; Cats; Cell Nucleus; Disease Models, Animal; DNA; Dopamine Agents; Fluorescent Dyes; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Necrosis; Nucleotidyltransferases; Parkinson Disease, Secondary; Staining and Labeling; Substantia Nigra	1997

Article

Year

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

Neuroscience, 1997, Volume: 77, Issue:4

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acridine Orange; Animals; Apoptosis; Cats; Cell Nucleus; Disease Models, Animal; DNA; Dopamine Agents; Fluorescent Dyes; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Necrosis; Nucleotidyltransferases; Parkinson Disease, Secondary; Staining and Labeling; Substantia Nigra

1997